Journal article

Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial

Neonatal BCG vaccination is part of routine vaccination schedules in many developing countries; vaccination at school age has not been assessed in trials in low-income and middle-income countries. Catch-up BCG vaccination of school-age children who missed neonatal BCG vaccination could be indicated if it confers protection and is cost-effective. The researchers conducted a cluster-randomised trial (BCG REVAC) to estimate the effectiveness (efficacy given in routine settings) of school-age vaccination.

Languages

  • English

Publication year

2012

Journal

Lancet Infect Dis.

Volume

4

Type

Journal article

Categories

  • Service delivery

Countries

  • Brazil

Tags

  • Campaign
  • Coverage monitoring

WHO Regions

  • Region of the Americas

Added by: Moderator

Added on: 2016-01-10 14:49:17

Hits: 657